Related Experiment Video
Updated: Aug 5, 2026

SA-β-Galactosidase-Based Screening Assay for the Identification of Senotherapeutic Drugs
Published on: June 28, 2019
Cellular senescence at the bidirectional interface between ageing and coronary artery disease
Xinxin Li1, Hanwen Zhang1, Mengjia Chen1
1Department of Cardiovascular Ultrasound, The First Hospital of China Medical University, Shenyang, Liaoning, China; Clinical Medical Research Centre of Imaging in Liaoning Province, Shenyang, Liaoning, China.
Cellular senescence, a hallmark of aging, contributes to coronary artery disease (CAD) by promoting inflammation and plaque instability. Targeting senescent cells may offer new therapeutic strategies for CAD in aging populations.
Area of Science:
- Cardiovascular Medicine
- Gerontology
- Cell Biology
Background:
- Coronary artery disease (CAD) is a leading cause of death globally, with aging populations presenting complex clinical challenges.
- Biological aging, beyond chronological age, is crucial for understanding CAD heterogeneity in older adults.
- Cellular senescence, marked by cell-cycle arrest and a senescence-associated secretory phenotype (SASP), links aging to cardiovascular disease.
Purpose of the Study:
- To review the role of cellular senescence in the context of coronary artery disease (CAD) and aging.
- To explore the bidirectional relationship between biological aging processes and CAD.
- To discuss potential therapeutic strategies targeting cellular senescence for CAD.
Main Methods:
- Literature review examining cell-type-specific senescence in cardiovascular compartments.
- Analysis of molecular pathways involved in senescence and CAD.
- Discussion of senolytic and senomorphic therapies in preclinical cardiovascular disease models.
Main Results:
- Senescent cells (endothelial, smooth muscle, immune, fibroblasts, cardiomyocytes) contribute to endothelial dysfunction, inflammation, and plaque instability in CAD.
- CAD-related stressors can induce local senescence, propagating signaling.
- The impact of CAD on whole-organism biological aging requires further investigation.
Conclusions:
- Cellular senescence acts as a bidirectional interface between aging and CAD, influenced by context.
- Senescence-targeted therapies (senolytics, senomorphics) show promise but are largely preclinical for cardiovascular disease.
- Future translation requires careful consideration of disease stage, timing, cell specificity, and patient stratification for refined, aging-informed CAD management.
Related Concept Videos
Coronary Artery Disease II: Pathophysiology
Replicative Cell Senescence
Replicative Cell Senescence
Mitochondria
Coronary Artery Disease I: Introduction
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
